INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

Key Takeaways Incyte touched a 52-week high of $87.24 on Aug. 18 after strong results and pipeline progress.Jakafi sales rose 15% to $1.5B in 1H 2025, while Opzelura jumped 37% to $283M.FDA approvals for Monjuvi and Zynyz expand Incytes oncology portfolio and boost growth.Incyte ((INCY) has put up a stupendous performance in the past month and touched a new 52-week high of $87.24 on Aug. 18. Nonetheless, the stock price dipped to $85.46 on the following day. Shares of the company have gained 26.8% compared ...